Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InspireMD (NSPR) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to -$13.1 million.

  • InspireMD's Net Income towards Common Stockholders fell 5423.07% to -$13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.9 million, marking a year-over-year decrease of 5661.57%. This contributed to the annual value of -$32.0 million for FY2024, which is 6069.99% down from last year.
  • Per InspireMD's latest filing, its Net Income towards Common Stockholders stood at -$13.1 million for Q3 2025, which was down 5423.07% from -$13.0 million recorded in Q2 2025.
  • InspireMD's Net Income towards Common Stockholders' 5-year high stood at -$3.2 million during Q1 2021, with a 5-year trough of -$13.1 million in Q3 2025.
  • In the last 5 years, InspireMD's Net Income towards Common Stockholders had a median value of -$5.3 million in 2023 and averaged -$6.6 million.
  • As far as peak fluctuations go, InspireMD's Net Income towards Common Stockholders plummeted by 8546.7% in 2021, and later soared by 223.16% in 2023.
  • InspireMD's Net Income towards Common Stockholders (Quarter) stood at -$4.1 million in 2021, then fell by 18.88% to -$4.8 million in 2022, then decreased by 20.57% to -$5.8 million in 2023, then plummeted by 61.28% to -$9.4 million in 2024, then tumbled by 39.33% to -$13.1 million in 2025.
  • Its last three reported values are -$13.1 million in Q3 2025, -$13.0 million for Q2 2025, and -$11.5 million during Q1 2025.